SLC5A10 and neutropenia: In the light of these results, SGLT5 can therefore to be considered a modifier gene for the neutropenia in G6PC3-deficient and GSD1b patients, which certainly underlines the importance of measuring blood 1,5-AG before and in the follow-up of the treatment of the neutropenia in these patients.